Stay updated on NIVO-IPI-TAXANE in Metastatic NSCLC Clinical Trial
Sign up to get notified when there's something new on the NIVO-IPI-TAXANE in Metastatic NSCLC Clinical Trial page.

Latest updates to the NIVO-IPI-TAXANE in Metastatic NSCLC Clinical Trial page
- Check6 days agoChange DetectedAdded Revision: v3.4.2; removed the government funding lapse notice and the previous Revision: v3.4.1 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check13 days agoChange DetectedAdded a site-wide government funding notice and a page revision tag (v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check20 days agoChange DetectedNew additions include a glossary display and status indicators such as 'Results First Posted' and 'Last Update Posted'. The page also removes older fields (e.g., 'Results First Posted (Estimated)', 'Last Update Submitted that met QC Criteria', 'Last Update Posted (Estimated)', and 'No FEAR Act data') and updates the revision to v3.4.0.SummaryDifference0.3%

- Check34 days agoChange DetectedRevision tag v3.3.4 has been added and revision tag v3.3.3 has been removed.SummaryDifference0.1%

- Check55 days agoChange DetectedAdded a Locations section showing North Carolina as a study site. Removed the HHS Vulnerability Disclosure link and updated the revision to v3.3.3.SummaryDifference0.2%

- Check84 days agoChange DetectedFooter now displays Revision: v3.3.2, replacing the previous v3.2.0. This is a minor version update with no changes to study details or page structure. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to NIVO-IPI-TAXANE in Metastatic NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NIVO-IPI-TAXANE in Metastatic NSCLC Clinical Trial page.